Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

IMPC Term

decreased blood urea nitrogen ... 1 | 31
decreased circulating LDL chol... 1 | 37
decreased mean corpuscular vol... 1 | 50
increased circulating LDL chol... 1 | 15
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 93

Disease

Cancer 4 | 2,346
malignant mesothelioma 3 | 3,162
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
subependymal giant cell astrocytoma 3 | 2,287
Adenoid Cystic Carcinoma 2 | 99
Carcinoma 2 | 2,147
Kidney cancer 2 | 118
Liver carcinoma 2 | 217
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse 2 | 12
Mammary Neoplasms 2 | 410
Salivary Gland Neoplasms 2 | 45
Vascular disease 2 | 281
cystic fibrosis 2 | 1,665
ductal carcinoma in situ 2 | 1,745
interstitial cystitis 2 | 2,299
lung cancer 2 | 4,466
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
Adenocarcinoma 1 | 115
Adenoma 1 | 165
Alzheimer's disease 1 | 644
Anemia 1 | 252
Angiomyolipoma 1 | 17
Animal Mammary Neoplasms 1 | 136
Asthenopia 1 | 11
Autistic Disorder 1 | 320
Brain Neoplasms 1 | 23
Carcinoma, Small Cell 1 | 8
Carcinoma, Transitional Cell 1 | 31
Chronic Lymphocytic Leukemia 1 | 242
Colonic Neoplasms 1 | 126
Colorectal Neoplasms 1 | 217
Diarrhea 1 | 155
Epilepsy 1 | 346
Esophageal Neoplasms 1 | 67
Exanthem 1 | 39
Familial adenomatous polyposis 1 | 31
Gastrointestinal system disease 1 | 50
Globe disease 1 | 57
Gout 1 | 93
Hemangiosarcoma 1 | 18
Hormone receptor positive malignant neoplasm of breast 1 | 10
Hyperglycemia 1 | 120
Hyperparathyroidism 1 | 43
Hyperplasia 1 | 26
Hypertensive disease 1 | 193
IGA Glomerulonephritis 1 | 454
Intestinal Polyps 1 | 5
Intestinal benign neoplasm 1 | 11
Invasive Ductal Breast Carcinoma 1 | 9
Kidney Neoplasm 1 | 27
Kidney disease 1 | 396
Large intestine cancer 1 | 12
Left Ventricular Hypertrophy 1 | 24
Leukemia 1 | 88
Leukopenia 1 | 42
Lung Neoplasms 1 | 171
Lupus erythematosus 1 | 80
Lymphocele 1 | 7
Mammary Neoplasms, Experimental 1 | 150
Mesothelioma 1 | 40
Metabolic syndrome X 1 | 155
Myocardial Ischemia 1 | 169
Neoplasms, Experimental 1 | 33
Neoplastic Cell Transformation 1 | 81
Neurofibromatosis 1 | 37
Neurotoxicity Syndromes 1 | 26
Papilloma 1 | 27
Parkinson's disease 1 | 364
Polycystic kidney disease 1 | 54
Precancerous Conditions 1 | 69
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 | 18
Primary hyperparathyroidism 1 | 4
Renal Cell Carcinoma 1 | 199
Spindle cell hemangioma 1 | 16
Squamous cell carcinoma of esophagus 1 | 82
Stomach Neoplasms 1 | 282
Stomatitis 1 | 19
Thrombocytopenia 1 | 105
Thyroid Neoplasm 1 | 33
Toxoplasmosis 1 | 16
Tularemia 1 | 22
Urologic Neoplasms 1 | 7
Uterine Cervical Neoplasm 1 | 21
Von Hippel-Lindau Syndrome 1 | 2
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
atypical teratoid/rhabdoid tumor 1 | 1,095
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
lung adenocarcinoma 1 | 2,713
mucosa-associated lymphoid tissue lymphoma 1 | 480
nasopharyngeal carcinoma 1 | 1,056
ovarian neoplasm 1 | 97
sarcoidosis 1 | 358
spina bifida 1 | 1,064
tuberculosis 1 | 1,557

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 3 | 11,971
Kinase 2 | 634

Grant Application

5R01CA112199-03 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
G1/S-specific cyclin-D1 CCND1 Tchem Non-IDG -3.77851 5447.1 1111
Serine/threonine-protein kinase MARK2 MARK2 Tchem Kinase -2.46742 259.6 291
BAG family molecular chaperone regulator 1 BAG1 Tbio Non-IDG -2.48320 329.1 359
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Serine/threonine-protein kinase mTOR MTOR Tclin Kinase -3.80360 6900.5 966